About Nature Care Cosmetics
Nature Care Cosmetics is an entrepreneurial driven company which often works in partnership with other companies. We want to be one of the most admired distributors in the country, covering all levels in the industry. We have 3 sales divisions: Branded Prescription, Generics, and Consumer in Cosmetics & planned expansions to the surgical & cosmetic segments. We have a dynamic team of sales & marketing delegates.
Although the Branded Prescription Business has an emphasis on brand building and marketing a product on its merits, we also have plans to tap the large Generics Business with the recently introduced health policy in Sri Lanka.
Company Philosophy
We aim to have a company culture where all employees are valued and treated with respect, and working in concert to achieve company goals. We see opportunities in products that others may look to divest for reasons of post-merger focus, regulatory issues or lack of financial viability.
We respond quickly to our customers and to market conditions and we make quick, but considered, decisions. While others pay lip-service to customer service, we genuinely believe that the customer is paramount. We are specialists in turning around declining products and we have proven success in product life-cycle management. We revitalize brands through innovative marketing and superlative customer service.
Strategic Intent
We will establish a competitive and compelling difference we can preserve within the retailing industry.
We will capitalize on the first mover advantage already established with Priceline, through significant investment.
Chairman s Message
“Nature Care Cosmetics remains a small and agile company with a track record to take a leading position in select niches in the Cosmetics market. In a short time, we have built a profitable Cosmetics company that offers several unique products in Sri Lanka. Our organization for marketing OTC brands is a valuable platform in our work to build a different kind of Cosmetics Company. We see great opportunities to increase the use of our existing products and introduce a number of unique treatments to the market – as part of creating additional value for patients, physicians and shareholders.”
Chairman / MD